- Home
- SNN vs AFRM Comparison
SNN vs AFRM Comparison
Compare SNN & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNN | AFRM |
|---|---|---|
| Founded | 1856 | 2012 |
| Country | United Kingdom | United States |
| Employees | 16988 | N/A |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 14.3B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNN | AFRM |
|---|---|---|
| Price | $30.40 | $63.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 25 |
| Target Price | $36.25 | ★ $84.52 |
| AVG Volume (30 Days) | 943.6K | ★ 4.7M |
| Earning Date | 03-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.42% | N/A |
| EPS Growth | N/A | ★ 108.98 |
| EPS | N/A | ★ 0.60 |
| Revenue | N/A | ★ $3,224,412,000.00 |
| Revenue This Year | $8.58 | $30.78 |
| Revenue Next Year | $5.60 | $23.95 |
| P/E Ratio | ★ $64.97 | $105.03 |
| Revenue Growth | N/A | ★ 38.80 |
| 52 Week Low | $28.02 | $42.10 |
| 52 Week High | $38.79 | $100.00 |
Technical Indicators
Market Signals| Indicator | SNN | AFRM |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 63.24 |
| Support Level | N/A | $61.46 |
| Resistance Level | $33.89 | $79.27 |
| Average True Range (ATR) | 0.61 | 3.05 |
| MACD | -0.28 | 0.56 |
| Stochastic Oscillator | 0.69 | 75.20 |
Price Performance
Historical ComparisonAbout SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
About AFRM Affirm Holdings Inc.
Founded in 2012, Affirm is a market leader in the buy-now, pay-later space with around $36 billion in transaction volume in fiscal 2025. Affirm offers both zero-interest financing, which is merchant subsidized, and interest-bearing loans, which function as personal loans that are approved on a per-transaction basis. Over 70% of Affirm's transaction volume comes from its interest-bearing loans, which also comprise the majority of its revenue. Affirm operates in the United States, which accounted for more than 95% of its revenue in 2025, but the firm has also expanded to Canada and the United Kingdom.